Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis.
T. Aoyama,H. Ishii,T. Toriyama,Hiroshi Takahashi,Hirotake Kasuga,Ryuichiro Murakami,T. Amano,T. Uetani,Y. Yasuda,Y. Yuzawa,S. Maruyama,S. Matsuo,T. Matsubara,T. Murohara
DOI: https://doi.org/10.1253/CIRCJ.72.56
Circulation Journal
Abstract:BACKGROUND
Accelerated atherosclerosis is a major risk for long-term survivors receiving hemodialysis (HD), with coronary events being the leading cause of mortality.
METHODS AND RESULTS
A total of 88 consecutive patients on HD (121 lesions) who underwent percutaneous coronary intervention (PCI) with sirolimus-eluting stents (SES) were compared with 78 patients on HD (95 lesions) who received bare metal stents (BMS) in the preceding 1 year. The primary endpoint was angiographic restenosis defined as > or =50% diameter stenosis at 6-8 months follow-up after PCI. The angiographic restenosis rate at follow-up was 22.2% in the SES group and 24.4% in the BMS group. No difference was detected in the restenosis rate between the 2 groups (p=0.73). When including both HD and non-HD patients, the independent predictors for restenosis after SES implantation were treatment with HD (hazard ratio (HR) 3.12; 95% confidence interval (CI) 1.23-7.95; p=0.016), incidence of hyperlipidemia (HR 3.93; 95%CI 1.12-13.7; p=0.032), coronary calcification (HR 2.78; 95%CI 1.12-6.91; p=0.027), and implantation of multi-stents (HR 4.14; 95%CI 1.70-10.1; p=0.0017).
CONCLUSIONS
Even if treated with SES, patients with end-stage renal failure on HD are at high risk of restenosis after PCI.